Method for detecting or treating triple negative breast cancer
AssigneeChildren's Medical Center Corporation
InventorsDebra Auguste, Marsha A. Moses, Peng Guo
Life of this patent
Estimating the term…
Abstract
A method of detecting triple negative breast cancer (TNBC) is provided. Overexpression of ICAM-1 is linked to an increased risk of TNBC. A composition of matter is also provided that binds an anti-ICAM˜1 antibody to a nanoparticle. The composition may be used as an imaging agent and/or a therapeutic targeting agent. A therapeutically active molecule may be bound to the composition to provide targeted therapy.
Claims5
A method of treating triple negative breast cancer (TNBC) in a patient, the method comprising administering enlimomab to the patient, wherein administering the enlimomab reduces TNBC cell migration in the patient.
Dependencies are inferred from the claim text.